20 participants
Study to Evaluate Biomarkers and Safety of Dapagliflozin Concomitant With Neoadjuvant Therapy
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-05-22
- Start Date:
- 2024-10-15
- Completion:
- 2027-12-31
Conditions
- Breast Cancer
- Hyperinsulinism
- HER2-negative Breast Cancer
Interventions
- DRUG
No Results Yet